178 related articles for article (PubMed ID: 23891099)
21. Dose-volumetric parameters for predicting hypothyroidism after radiotherapy for head and neck cancer.
Kim MY; Yu T; Wu HG
Jpn J Clin Oncol; 2014 Apr; 44(4):331-7. PubMed ID: 24482412
[TBL] [Abstract][Full Text] [Related]
22. The incidence of hypothyroidism after radiotherapy for head and neck cancer.
Pil J; Nevens D; Van der Vorst A; Gadan C; Nuyts S
B-ENT; 2016; 12(4):257-262. PubMed ID: 29709128
[TBL] [Abstract][Full Text] [Related]
23. Relation of External Beam Radiotherapy Dose with Subclinical Hypothyroidism in Patients undergoing Adjuvant Neck Radiation after Surgery for Squamous Cell Carcinoma of Head and Neck.
Uddin N; Iqbal M; Hashmi H
J Coll Physicians Surg Pak; 2021 Mar; 31(3):359-360. PubMed ID: 33775035
[TBL] [Abstract][Full Text] [Related]
24. Thyroid V50 Highly Predictive of Hypothyroidism in Head-and-Neck Cancer Patients Treated With Intensity-modulated Radiotherapy (IMRT).
Sachdev S; Refaat T; Bacchus ID; Sathiaseelan V; Mittal BB
Am J Clin Oncol; 2017 Aug; 40(4):413-417. PubMed ID: 25503434
[TBL] [Abstract][Full Text] [Related]
25. Quantitative analysis of normal tissue effects in the clinic (QUANTEC) guideline validation using quality of life questionnaire datasets for parotid gland constraints to avoid causing xerostomia during head-and-neck radiotherapy.
Lee TF; Fang FM
Radiother Oncol; 2013 Mar; 106(3):352-8. PubMed ID: 23333019
[TBL] [Abstract][Full Text] [Related]
26. Post-radiation primary hypothyroidism in patients with head and neck cancer: External validation of thyroid gland dose-volume constraints with long-term endocrine outcomes.
Chow JCH; Lui JCF; Cheung KM; Tam AHP; Lam MHC; Yuen TYS; Lee FKH; Leung AKC; Au KH; Ng WT; Lee AWM; Kwan CK; Yiu HHY
Radiother Oncol; 2022 Dec; 177():105-110. PubMed ID: 36336109
[TBL] [Abstract][Full Text] [Related]
27. Hypothyroidism in patients treated with radiotherapy for head and neck carcinoma: standardised long-term follow-up study.
Alba JR; Basterra J; Ferrer JC; Santonja F; Zapater E
J Laryngol Otol; 2016 May; 130(5):478-81. PubMed ID: 26975210
[TBL] [Abstract][Full Text] [Related]
28. Dose-volume predictors of post-radiation primary hypothyroidism in head and neck cancer: A systematic review.
Chow JCH; Cheung KM; Cheung GTC; Tam AHP; Lui JCF; Lee FKH; Au KH; Ng WT; Lee AWM; Yiu HHY
Clin Transl Radiat Oncol; 2022 Mar; 33():83-92. PubMed ID: 35128087
[TBL] [Abstract][Full Text] [Related]
29. Hypothyroidism after radiotherapy of head and neck cancer.
Bernát L; Hrušák D
J Craniomaxillofac Surg; 2014 Jun; 42(4):356-61. PubMed ID: 24210455
[TBL] [Abstract][Full Text] [Related]
30. Dosimetric predictors of hypothyroidism in oropharyngeal cancer patients treated with intensity-modulated radiation therapy.
Chyan A; Chen J; Shugard E; Lambert L; Quivey JM; Yom SS
Radiat Oncol; 2014 Dec; 9():269. PubMed ID: 25476839
[TBL] [Abstract][Full Text] [Related]
31. Thyroid dysfunction following radiotherapy for head and neck cancer.
Turner SL; Tiver KW; Boyages SC
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):279-83. PubMed ID: 7836081
[TBL] [Abstract][Full Text] [Related]
32. Hypothyroidism after 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for head and neck cancers: prospective data from 2 randomized controlled trials.
Murthy V; Narang K; Ghosh-Laskar S; Gupta T; Budrukkar A; Agrawal JP
Head Neck; 2014 Nov; 36(11):1573-80. PubMed ID: 23996654
[TBL] [Abstract][Full Text] [Related]
33. NTCP model for hypothyroidism after supraclavicular-directed radiation therapy for breast cancer.
Huang H; Roberson J; Hou W; Mani K; Valentine E; Ryu S; Stessin A
Radiother Oncol; 2021 Jan; 154():87-92. PubMed ID: 32926911
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia-targeted radiotherapy dose painting for head and neck cancer using (18)F-FMISO PET: a biological modeling study.
Chang JH; Wada M; Anderson NJ; Lim Joon D; Lee ST; Gong SJ; Gunawardana DH; Sachinidis J; O'Keefe G; Gan HK; Khoo V; Scott AM
Acta Oncol; 2013 Nov; 52(8):1723-9. PubMed ID: 23317145
[TBL] [Abstract][Full Text] [Related]
35. Helical tomotherapy for head and neck squamous cell carcinoma: dosimetric comparison with linear accelerator-based step-and-shoot IMRT.
Murthy V; Master Z; Gupta T; Ghosh-Laskar S; Budrukkar A; Phurailatpam R; Agarwal J
J Cancer Res Ther; 2010; 6(2):194-8. PubMed ID: 20622367
[TBL] [Abstract][Full Text] [Related]
36. Normal tissue complication probability modeling of acute hematologic toxicity in patients treated with intensity-modulated radiation therapy for squamous cell carcinoma of the anal canal.
Bazan JG; Luxton G; Mok EC; Koong AC; Chang DT
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):700-6. PubMed ID: 22414279
[TBL] [Abstract][Full Text] [Related]
37. Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer.
Diaz R; Jaboin JJ; Morales-Paliza M; Koehler E; Phillips JG; Stinson S; Gilbert J; Chung CH; Murphy BA; Yarbrough WG; Murphy PB; Shyr Y; Cmelak AJ
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):468-76. PubMed ID: 19577867
[TBL] [Abstract][Full Text] [Related]
38. Thyroid dose-volume thresholds for the risk of radiation-related hypothyroidism in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy-A single-institution study.
Huang CL; Tan HW; Guo R; Zhang Y; Peng H; Peng L; Lin AH; Mao YP; Sun Y; Ma J; Tang LL
Cancer Med; 2019 Nov; 8(16):6887-6893. PubMed ID: 31560840
[TBL] [Abstract][Full Text] [Related]
39. Hypothyroidism after external radiotherapy for head and neck cancer.
Tell R; Sjödin H; Lundell G; Lewin F; Lewensohn R
Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):303-8. PubMed ID: 9308932
[TBL] [Abstract][Full Text] [Related]
40. Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck.
Colevas AD; Read R; Thornhill J; Adak S; Tishler R; Busse P; Li Y; Posner M
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):599-604. PubMed ID: 11597798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
